| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Exagen Inc.
13G/A
Amendment 8
XGN · 30068X103
|
3.4% |
11/13/2026
Event 10/28/2026
|
|||
| NMSIC Co-Investment Fund, L.P. | 3.4% | ||||
| Sun Mountain Capital Partners, L.L.C. | 3.4% | ||||
|
Exagen Inc.
13G/A
Amendment 7
XGN · 30068X103
|
6.0% |
2/11/2026
Event 12/31/2025
|
|||
| NMSIC Co-Investment Fund, L.P. | 6.0% | ||||
| Sun Mountain Capital Partners, L.L.C. | 6.0% | ||||
|
Exagen Inc.
13G/A
Amendment 6
XGN · 30068X103
|
9.8% |
4/17/2025
Event 3/25/2025
|
|||
| NMSIC Co-Investment Fund, L.P. | 9.8% | ||||
| Sun Mountain Capital Partners, L.L.C. | 9.8% | ||||
|
Exagen Inc.
13G/A
Amendment 5
XGN · 30068X103
|
12.0% |
1/29/2025
Event 12/31/2024
|
|||
| NMSIC Co-Investment Fund, L.P. | 12.0% | ||||
| Sun Mountain Capital Partners LLC | 12.0% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.